Ozempic maker Novo Nordisk boots CEO over stock-price fall - MarketWatch
1. Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down after eight years. 2. Novo Nordisk stock has lost half its value since its summer peak. 3. The company faces intense competition from Eli Lilly and others. 4. Recent market challenges have led to leadership changes at Novo Nordisk. 5. Novo Nordisk stock dropped 3% in premarket trading following the announcement.